Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Sex Transm Dis. 2019 May;46(5):312–316. doi: 10.1097/OLQ.0000000000000968

Table 3.

Time to first negative T. vaginalis NAAT test by selected variables (n=89)

Median (min-max
range) [IQR]
Log-Rank (for
comparison)
Metronidazole Dose
  Single 9(6-28) [7-14] 0.04
  Multi 7(7-20) [7-10]
Douching*
  Yes 8 (6, 22) [7-14] 0.87
  No 8 (7, 28) [7-12]
Baseline Symptoms**
  Yes 8 (6-28) [7-12] 0.81
  No 8 (6-19) [7-13]
History of T. vaginalis
  Yes 8 (6-28) [7-11] 0.58
  No 8 (6-23) [7-14]
Bacterial Vaginosis
  Yes 8 (6-23) [7-12] 0.30
  No 8 (6-34) [7-14]
*

Douching defined as any douching in the 30 months prior to the baseline visit.

**

Baseline symptom is defined as having any one (or more) of the following: vaginal discharge, vaginal odor, vaginal itching or irritation, pain while urinating, pelvic pain, or other vaginal complaints.